Informed-money record

SNDX · Syndax Pharmaceuticals Inc

Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.

Bullish filings

2

Bearish filings

29

Named actors

6

Disclosed $ (bull / bear)

$21K / $12.6M

Recent disclosures

25 of 31 in the window · linked to source
DateWhoWhatDisclosed $Receipt
2026-07-08Chief Executive Officer Metzger Michael Asold$785KSEC ↗
2026-07-08Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MICHAEL METZGERfiled notice to sell$752KSEC ↗
2026-06-12Head of R&D, CMO Botwood Nicholas A.J.sold$567KSEC ↗
2026-06-12Officer (via Fidelity Brokerage Services LLC) Botwood Nicholas A.J.filed notice to sell$567KSEC ↗
2026-06-11Head of R&D, CMO Botwood Nicholas A.J.sold$617KSEC ↗
2026-06-11Officer (via Fidelity Brokerage Services LLC) Botwood Nicholas A.J.filed notice to sell$609KSEC ↗
2026-06-01Chief Executive Officer Metzger Michael Asold$130KSEC ↗
2026-06-01Chief Financial Officer Goldan Keith A.sold$22KSEC ↗
2026-06-01Officer (via Fidelity Brokerage Services LLC) Metzger Michael Afiled notice to sell$130KSEC ↗
2026-06-01Officer (via Fidelity Brokerage Services LLC) Goldan Keith A.filed notice to sell$22KSEC ↗
2026-02-09Chief Financial Officer Goldan Keith A.sold$72KSEC ↗
2026-02-09Chief Executive Officer Metzger Michael Asold$361KSEC ↗
2026-02-09Officer (via Fidelity Brokerage Services LLC) Goldan Keith A.filed notice to sell$72KSEC ↗
2026-02-09Officer (via Fidelity Brokerage Services LLC) Metzger Michael Afiled notice to sell$361KSEC ↗
2026-02-06Chief Financial Officer Goldan Keith A.sold$43KSEC ↗
2026-02-06Chief Executive Officer Metzger Michael Asold$153KSEC ↗
2026-02-06Officer (via Fidelity Brokerage Services LLC) Goldan Keith A.filed notice to sell$43KSEC ↗
2026-02-06Officer (via Fidelity Brokerage Services LLC) Metzger Michael Afiled notice to sell$153KSEC ↗
2026-01-30Chief Financial Officer Goldan Keith A.acquired shares (non-open-market)$10KSEC ↗
2025-09-08Chief Executive Officer Metzger Michael Asold$2.6MSEC ↗
2025-09-08Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) MICHAEL METZGERfiled notice to sell$2.7MSEC ↗
2025-08-18Director Podlesak Dennissold$304KSEC ↗
2025-08-18Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) DENNIS G PODLESAKfiled notice to sell$227KSEC ↗
2025-08-15Director Podlesak Dennissold$298KSEC ↗
2025-08-14Director Podlesak Dennissold$272KSEC ↗

6 more disclosures in the window — the full record, scoring, and validation are for members.

Want the read, not just the record?

Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.

Create a free account →
Dispute or correct this record

This page is a dated factual record built from public filings, each row linked to its source. If a row is wrong — a misattributed filing, a wrong name, a record that should not merge — tell us what and why.

Reviewed by a human; the page never changes automatically.

Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals